“Conpositions and methods for inducing tissue or organ regeneration” U.S. Provisional Application: #63/929,185.
“Cellular compositions comprising mesenchymal stem cells and methods of making and using the same” U.S. Provisional Application: # 63/813,053.
We have successfully created implantable, biomaterial-free pellets of human adipose-derived mesenchymal stromal cells (MSCs) that continuously secrete therapeutic factors in vivo and function as a “living drug.” This approach has the potential to transform current MSC-based therapy.
Fabricated biomaterial-free human MSCs pellet before implantation.
Implantation of human mesenchymal stromal cell (MSC)-pellet for therapeutic angiogenesis.
“Effects of age-dependent changes in cell size on endothelial cell growth” United State Patent Application Publication: US 2022/0175730A1 June 9 2022.